Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period

J. von Braun, A. Deodhar, B.A.C. Dijkmans, P.P.M.M. Geusens, J. Sieper, P. Williamson, W. Xu, S. Visvanathan, D. Baker, N. Goldstein, D.M. Van der Heijde

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1270-1278
JournalArthritis & Rheumatism
Volume59
Issue number9
DOIs
Publication statusPublished - 2008

Cite this

von Braun, J., Deodhar, A., Dijkmans, B. A. C., Geusens, P. P. M. M., Sieper, J., Williamson, P., ... Van der Heijde, D. M. (2008). Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period. Arthritis & Rheumatism, 59(9), 1270-1278. https://doi.org/10.1002/art.24001